Top compounds associated with response to RPS2


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA Platin CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.07 0.3
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.4
mRNA ML320 CTRPv2 pan-cancer AAC -0.034 0.4
Download CSV